Vaalia Health is co-organizing The Next Frontier in Cancer Care, an official Slush-week event in Helsinki on November 19, 2025. The gathering brings together leading oncology innovators, researchers, and industry executives to examine how data, diagnostics, and advanced AI are reshaping the delivery of cancer care.

Cancer treatment is entering a period of rapid advancement: dozens of new therapies have been introduced in recent years, and hundreds more are in late-stage development. At the same time, rising incidence and workforce pressures are widening the gap between therapeutic breakthroughs and their implementation in everyday clinical practice. This event will explore how next-generation technologies can help close this gap and meaningfully improve patient experience and outcomes.

The program features a panel discussion moderated by Svetlana Nikic, Founder of Precision Oncology Consulting, with participation from leaders across oncology research and high-growth startups. Vaalia Health’s Chief Medical Officer, Dr. Ken Carson, will join experts from HederaDx, Gosta Labs, and Solid IO to discuss the role of AI, real-world evidence, and patient-centered tools in advancing cancer care.

By convening this forum, Vaalia aims to deepen dialogue across the oncology ecosystem and highlight the importance of practical, scalable innovations that support patients and clinicians navigating increasingly complex therapies.